Rankings
▼
Calendar
CRMD Q2 2023 Earnings — CorMedix Inc. Revenue & Financial Results | Market Cap Arena
CRMD
CorMedix Inc.
$536M
Q2 2023 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
-100.0% YoY
Gross Profit
-$50,748
Operating Income
-$12M
Net Income
-$11M
EPS (Diluted)
$-0.25
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$9M
Free Cash Flow
-$9M
Stock-Based Comp.
$1M
Balance Sheet
Total Assets
$57M
Total Liabilities
$8M
Stockholders' Equity
$49M
Cash & Equivalents
$20M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$21,253
-100.0%
Gross Profit
-$50,748
$20,921
-342.6%
Operating Income
-$12M
-$8M
-43.3%
Net Income
-$11M
-$8M
-48.2%
← FY 2023
All Quarters
Q3 2023 →